100 related articles for article (PubMed ID: 16446540)
1. Effect of smoking status on outcome after acute ischemic stroke.
Ovbiagele B; Weir CJ; Saver JL; Muir KW; Lees KR;
Cerebrovasc Dis; 2006; 21(4):260-5. PubMed ID: 16446540
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome after atherosclerotic stroke in male smoker.
Bang OY; Park HY; Lee PH; Kim GM; Chung CS; Lee KH
J Neurol Sci; 2007 Sep; 260(1-2):43-8. PubMed ID: 17477936
[TBL] [Abstract][Full Text] [Related]
3. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
4. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
[TBL] [Abstract][Full Text] [Related]
5. The smoking-thrombolysis paradox and acute ischemic stroke.
Ovbiagele B; Saver JL
Neurology; 2005 Jul; 65(2):293-5. PubMed ID: 16043802
[TBL] [Abstract][Full Text] [Related]
6. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
7. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
Ovbiagele B; Saver JL
Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
[TBL] [Abstract][Full Text] [Related]
8. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
Muir KW; Lees KR; Ford I; Davis S;
Lancet; 2004 Feb; 363(9407):439-45. PubMed ID: 14962524
[TBL] [Abstract][Full Text] [Related]
9. Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia.
Moulin S; Padjen-Bogosavljevic V; Marichal A; Cordonnier C; Jovanovic DR; Gautier S; Hénon H; Beslac-Bumbasirevic L; Bordet R; Leys D
Eur Neurol; 2012; 67(3):178-83. PubMed ID: 22286144
[TBL] [Abstract][Full Text] [Related]
10. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
11. The effect of statins on acute and long-term outcome after ischemic stroke in the elderly.
Hjalmarsson C; Bokemark L; Manhem K; Mehlig K; Andersson B
Am J Geriatr Pharmacother; 2012 Oct; 10(5):313-22. PubMed ID: 23063287
[TBL] [Abstract][Full Text] [Related]
12. Prolonged QTc as a predictor of mortality in acute ischemic stroke.
Stead LG; Gilmore RM; Bellolio MF; Vaidyanathan L; Weaver AL; Decker WW; Brown RD
J Stroke Cerebrovasc Dis; 2009; 18(6):469-74. PubMed ID: 19900651
[TBL] [Abstract][Full Text] [Related]
13. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial.
Aslanyan S; Fazekas F; Weir CJ; Horner S; Lees KR;
Stroke; 2003 Oct; 34(10):2420-5. PubMed ID: 14500934
[TBL] [Abstract][Full Text] [Related]
14. Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients.
Yoo SH; Kim JS; Kwon SU; Yun SC; Koh JY; Kang DW
Arch Neurol; 2008 Jan; 65(1):39-43. PubMed ID: 18195138
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.
Elkind MS; Flint AC; Sciacca RR; Sacco RL
Neurology; 2005 Jul; 65(2):253-8. PubMed ID: 16043795
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice.
Dirks M; Niessen LW; van Wijngaarden J; Koudstaal PJ; Franke CL; van Oostenbrugge RJ; Dippel DW;
Int J Stroke; 2012 Jun; 7(4):289-92. PubMed ID: 22168317
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis.
Bang OY; Saver JL; Liebeskind DS; Starkman S; Villablanca P; Salamon N; Buck B; Ali L; Restrepo L; Vinuela F; Duckwiler G; Jahan R; Razinia T; Ovbiagele B
Neurology; 2007 Mar; 68(10):737-42. PubMed ID: 17182976
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
Yong M; Diener HC; Kaste M; Mau J
Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
[TBL] [Abstract][Full Text] [Related]
19. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria and clinical outcomes after ischemic stroke.
Kumai Y; Kamouchi M; Hata J; Ago T; Kitayama J; Nakane H; Sugimori H; Kitazono T;
Neurology; 2012 Jun; 78(24):1909-15. PubMed ID: 22592359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
